
Red Sox decline club option for LHP Joely Rodriguez
The Red Sox announced Saturday they’ve declined left-hander Joely Rodriguez’s $4.25 million club option, making the oft-injured reliever a free agent.
Rodriguez, 31, was the first free agent signed by the Red Sox last winter, agreeing to a one-year, $2 million deal with the club option for 2024. Rodriguez was originally envisioned as the club’s top left-hander out of the bullpen, but his season was derailed by three separate trips to the injured list. The lefty ultimately appeared in only 11 games for Boston, posting a 6.55 ERA with a 1.727 WHIP in 11 innings.
Instead of the option, Rodriguez will now receive a $500,000 buyout and will be eligible to sign with any other team starting Monday.
The Red Sox decision came a day after the team also declined the $11 million club option for right-handed pitcher Corey Kluber, and after designated hitter Justin Turner declined his $13.4 million player option. With all three of Boston’s option decisions finalized, the team now has six free agents hitting the open market. Outfielder Adam Duvall, left-hander James Paxton and shortstop Adalberto Mondesi are the other three.
More Stories
Literary calendar for week of May 18
(Courtesy of the author) Alison McGhee (Courtesy of the author) ALISON MCGHEE: Bestselling Minnesota author who writes for all ages...
Lynne Peeples: On autism and vaccines, there are lies, damned lies and statistics
During an interview in late April with Dr. Phil, Robert F. Kennedy Jr. reiterated his appeal to parents on vaccine...
‘Friendship’ review: Tim Robinson, Paul Rudd in doppelganger ‘I Love You, Man’
Paul Rudd and Jason Segel dissected the nature of adult male friendships in 2009’s “I Love You, Man,” and Rudd...
Readers and writers: Selections for Mental Health Awareness Month
In the middle of Mental Health Awareness Month, we’re offering stories about forgotten people on the margins, a memoir about...
MLB notes: Red Sox wisely took less is more approach with new uniforms
Since Nike and MLB first introduced the City Connect uniform program in 2021, we’ve seen a handful of standout designs...
Lisa Jarvis: FDA appointee is a drug critic with a lot to prove
The controversial appointment of oncologist Vinay Prasad — an outspoken critic of the pharmaceutical industry and U.S. health agencies —...